COVID-19 got in the way of a lot of big plans, like that fitness routine that we totally would’ve gotten around to if the gym had been open. It also put the brakes on tons of sorely-needed scientific research. But the show must go on, and this week we find that things are looking especially…
It’s not often that the worlds of neurology, pulmonology, and oncology come together all at once, but this week, we’re bringing you a story that makes it happen, with an interesting set of benefits for all three specialties. That’s not all, though—we’ve got brand new bona fides for one of the most-prescribed migraine drugs, new…
During the last week of summer break (yes, it’s really here) we’re zooming out to take a look at the big picture in neurology. What can we do to push harder for new Parkinson’s therapies? How can we undo damage done by degenerative diseases? Why aren’t we paying closer attention to racial disparities in neurological…
This week, researchers added tons of new options to the neurologist’s diagnostic and preventive toolkit, including a simple algorithm to predict Parkinson’s disease risk, more robust data on common risk factors, and new biomarkers. But that’s not all. This week, we highlight several new treatments you’ll want to try (including the first self-administered B-cell therapy…
There’s a lot we still don’t know about COVID-19, but as time goes on the picture becomes a bit clearer. Unfortunately, it’s a pretty grim one. The virus has killed more than 775,000 people worldwide, damaged economies, and even those who survive tell stories of serious downstream difficulties, including some that affect cognition. In this…
